Skip to main content
Supplement ScienceSupplementScience

Types of Artichoke Extract: Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
Artichoke Leaf Extract (standardized to cynarin)ModerateStandard supplementation — most studied form, typically standardized to 2.5-5% cynarin
Artichoke Leaf Extract (standardized to caffeoylquinic acids)ModerateBroader spectrum — standardized to total caffeoylquinic acids including cynarin and chlorogenic acid

Artichoke Leaf Extract (standardized to cynarin)

Bioavailability: Moderate. Best for: Standard supplementation — most studied form, typically standardized to 2.5-5% cynarin.

Artichoke Leaf Extract (standardized to caffeoylquinic acids)

Bioavailability: Moderate. Best for: Broader spectrum — standardized to total caffeoylquinic acids including cynarin and chlorogenic acid.

Full Artichoke Extract Guide

References

  1. RCTHoltmann G, Adam B, Haag S, Collet W, Grünewald E, Windeck T (2003). Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Alimentary Pharmacology & Therapeutics. DOI PubMed
  2. Meta-analysisSahebkar A, Pirro M, Banach M, Mikhailidis DP, Atkin SL, Cicero AFG (2018). Lipid-lowering activity of artichoke extracts: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition. DOI PubMed
  3. RCTKirchhoff R, Beckers CH, Kirchhoff GM, Trinczek-Gärtner H, Petrowicz O, Reimann HJ (1994). Increase in choleresis by means of artichoke extract. Phytomedicine. DOI PubMed
  4. Cicero AFG, Corsini A (2026). The complex relationship between cardiologists and lipid-lowering dietary supplements: Hate or love?. Nutrition, metabolism, and cardiovascular diseases : NMCD. DOI PubMed
  5. Cicero AFG, Fogacci F, Tocci G, D'Addato S, et al. (2023). Three arms, double-blind, non-inferiority, randomized clinical study testing the lipid-lowering effect of a novel dietary supplement containing red yeast rice and artichoke extracts compared to Armolipid Plus® and placebo.. Archives of medical science : AMS. DOI PubMed
  6. Hosseinpour-Niazi S, Mirmiran P, Hosseini S, Hadaegh F, et al. (2022). Effect of TCF7L2 on the relationship between lifestyle factors and glycemic parameters: a systematic review.. Nutrition journal. DOI PubMed
  7. Fogacci F, Rizzoli E, Giovannini M, Bove M, et al. (2022). Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study.. Nutrients. DOI PubMed
Show 3 more references
  1. Meta-analysisShahinfar H, Bazshahi E, Amini MR, Payandeh N, et al. (2021). Effects of artichoke leaf extract supplementation or artichoke juice consumption on lipid profile: A systematic review and dose-response meta-analysis of randomized controlled trials.. Phytotherapy research : PTR. DOI PubMed
  2. Cicero AFG, Fogacci F, Bove M, Giovannini M, et al. (2019). Three-arm, placebo-controlled, randomized clinical trial evaluating the metabolic effect of a combined nutraceutical containing a bergamot standardized flavonoid extract in dyslipidemic overweight subjects.. Phytotherapy research : PTR. DOI PubMed
  3. Rechner AR, Pannala AS, Rice-Evans CA (2001). Caffeic acid derivatives in artichoke extract are metabolised to phenolic acids in vivo.. Free radical research. DOI PubMed